Terns Pharmaceuticals, Inc.TERNNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+20.4%
5Y CAGR+24.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+20.4%/yr
vs +35.4%/yr prior
5Y CAGR
+24.0%/yr
Recent deceleration
Acceleration
-15.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $108.37M | +6.4% |
| 2024 | $101.87M | -0.7% |
| 2023 | $102.56M | +65.3% |
| 2022 | $62.03M | +22.0% |
| 2021 | $50.86M | +37.4% |
| 2020 | $37.02M | -47.3% |
| 2019 | $70.20M | +280.4% |
| 2018 | $18.45M | - |